Advertiment
Boccon-Gibod L, Richaud P, Coloby P, Coulange C, Culine S, Davin JL, Soulié M, Zerbib M.
Clinique d’urologie, université Paris VII – Denis-Diderot, hôpital Bichat Claude-Bernard, 46, rue Henri-Huchard, 75877 Paris cedex 18, France.
The utilization of androgen deprivation therapy in prostate cancer has evolved over time. Unquestionably considered first line treatment in metastatic cancers or in case of lymph node involvement, it is increasingly used in locally advanced and high-risk cancers, combined with radiation therapy. However, the practical modalities of treatment are still controversial (neoadjuvant, concomitant/adjuvant) and should be discussed on a case-by-case basis, taking into account tumor stage and risk level, which depends mainly on Gleason score and PSA levels and kinetics. Hormone therapy is also indicated in case of systemic relapse, especially if PSA doubling time is less than 12 months. LHRH agonists have become the standard care; antiandrogens can be added at the beginning of the LHRH agonist therapy to obtain a complete androgen blockade. Intermittent androgen deprivation therapy has recently proved efficacious and might be more widely used in the future, provided that strict prescription and follow-up recommendations are clearly established. Copyright © 2009 Elsevier Masson SAS. All rights reserved.
Leave a Reply
Suggested Posts
Potential New Treatment For Kidney Cancer By Specific Inhibition Of Autophagy Bocco -Gibod L, Richaud P, Coloby P, Coula ge C, Culi e S, Davi JL, Soulié M, Zerbib M. Cli ique d’urologie, u iversité Paris VII – De is-Diderot, hôpital Bichat Claude-Ber ard, 46, rue He ri-Huchard, 75877 Paris cedex 18, Fra ce. The utilizatio of a droge deprivatio therapy i prostate ca cer has evolved over time. U questio ably co sidered first li e treatme t i metastatic ca cers [...]. Posted December 17th, 2009 | 6:55 pm
Treatment Of Gynecologic Cancers Reduced From 5 Weeks To 3 Days Using New Radiation Therapy Bocco -Gibod L, Richaud P, Coloby P, Coula ge C, Culi e S, Davi JL, Soulié M, Zerbib M. Cli ique d’urologie, u iversité Paris VII – De is-Diderot, hôpital Bichat Claude-Ber ard, 46, rue He ri-Huchard, 75877 Paris cedex 18, Fra ce. The utilizatio of a droge deprivatio therapy i prostate ca cer has evolved over time. U questio ably co sidered first li e treatme t i metastatic ca cers [...]. Posted December 17th, 2009 | 6:55 pm
Joint Clinical Practice Guidelines On Hepatocellular Carcinoma Management To Be Published By EASL-EORTC Bocco -Gibod L, Richaud P, Coloby P, Coula ge C, Culi e S, Davi JL, Soulié M, Zerbib M. Cli ique d’urologie, u iversité Paris VII – De is-Diderot, hôpital Bichat Claude-Ber ard, 46, rue He ri-Huchard, 75877 Paris cedex 18, Fra ce. The utilizatio of a droge deprivatio therapy i prostate ca cer has evolved over time. U questio ably co sidered first li e treatme t i metastatic ca cers [...]. Posted December 17th, 2009 | 6:55 pm
Potential Strategy Aims To Stimulate The Immune System To Defeat Cancers Bocco -Gibod L, Richaud P, Coloby P, Coula ge C, Culi e S, Davi JL, Soulié M, Zerbib M. Cli ique d’urologie, u iversité Paris VII – De is-Diderot, hôpital Bichat Claude-Ber ard, 46, rue He ri-Huchard, 75877 Paris cedex 18, Fra ce. The utilizatio of a droge deprivatio therapy i prostate ca cer has evolved over time. U questio ably co sidered first li e treatme t i metastatic ca cers [...]. Posted December 17th, 2009 | 6:55 pm
Roche medicine Avastin receives EU approval for the treatment of women with newly diagnosed, advanced ovarian cancer Bocco -Gibod L, Richaud P, Coloby P, Coula ge C, Culi e S, Davi JL, Soulié M, Zerbib M. Cli ique d’urologie, u iversité Paris VII – De is-Diderot, hôpital Bichat Claude-Ber ard, 46, rue He ri-Huchard, 75877 Paris cedex 18, Fra ce. The utilizatio of a droge deprivatio therapy i prostate ca cer has evolved over time. U questio ably co sidered first li e treatme t i metastatic ca cers [...]. Posted December 17th, 2009 | 6:55 pm